In today’s session Adeptus Health Inc (ADPT) recorded an unusually high (2,333) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the November, 2016 put, expecting serious ADPT decrease. With 2,333 contracts traded and 13764 open interest for the Nov, 16 contract, it seems this is a quite bearish bet. The option with symbol: ADPT161118P00025000 closed last at: $2.35 or 135% up. About 2.33M shares traded hands or 99.15% up from the average. Adeptus Health Inc (NYSE:ADPT) has declined 84.12% since April 1, 2016 and is downtrending. It has underperformed by 85.33% the S&P500.
Adeptus Health Inc (NYSE:ADPT) Ratings Coverage
Out of 7 analysts covering Adeptus Health (NYSE:ADPT), 4 rate it a “Buy”, 1 “Sell”, while 2 “Hold”. This means 57% are positive. $135 is the highest target while $62 is the lowest. The $95.33 average target is 1071.13% above today’s ($8.14) stock price. Adeptus Health has been the topic of 14 analyst reports since August 3, 2015 according to StockzIntelligence Inc. The rating was downgraded by Jefferies to “Hold” on Wednesday, November 2. The stock has “Market Outperform” rating given by JMP Securities on Wednesday, August 31. The company was downgraded on Wednesday, November 2 by Stephens. Piper Jaffray maintained it with “Overweight” rating and $130.0 target price in Thursday, August 13 report. The rating was maintained by Dougherty & Company with “Buy” on Wednesday, November 18. Bank of America downgraded the shares of ADPT in a report on Wednesday, November 2 to “Underperform” rating. As per Monday, August 3, the company rating was initiated by Jefferies. The stock of Adeptus Health Inc (NYSE:ADPT) earned “Outperform” rating by RBC Capital Markets on Friday, July 24. The stock of Adeptus Health Inc (NYSE:ADPT) has “Overweight” rating given on Friday, September 18 by KeyBanc Capital Markets. RBC Capital Markets maintained Adeptus Health Inc (NYSE:ADPT) rating on Friday, October 23. RBC Capital Markets has “Outperform” rating and $92 price target.
According to Zacks Investment Research, “Adeptus Health, Inc. owns and operates First Choice Emergency Room, the network of independent freestanding emergency rooms in the United States. The Company provides emergency medical care to patients in Texas and Colorado. It has developed a facility design and infrastructure specifically tailored to the emergency care delivery system that combines staff, equipment and physical layout to deliver care. Adeptus Health Inc. is based in Lewisville, Texas.”
Insitutional Activity: The institutional sentiment increased to 1.96 in Q2 2016. Its up 0.04, from 1.92 in 2016Q1. The ratio increased, as 29 funds sold all Adeptus Health Inc shares owned while 25 reduced positions. 22 funds bought stakes while 84 increased positions. They now own 21.33 million shares or 18.77% more from 17.95 million shares in 2016Q1.
Moreover, Massachusetts Fincl Services Ma has 0.01% invested in Adeptus Health Inc (NYSE:ADPT) for 321,881 shares. Balyasny Asset Mngmt Lc has 0.06% invested in the company for 186,359 shares. Moreover, Royal State Bank Of Canada has 0% invested in Adeptus Health Inc (NYSE:ADPT) for 136,918 shares. State Of Tennessee Treasury Department holds 0% or 10,819 shares in its portfolio. Nicholas Prns L P, a California-based fund reported 50,817 shares. Moreover, Miles Capital Inc has 0.16% invested in Adeptus Health Inc (NYSE:ADPT) for 4,581 shares. Prudential Inc, a New Jersey-based fund reported 164,633 shares. Moreover, Tci Wealth Advsrs has 0% invested in Adeptus Health Inc (NYSE:ADPT) for 24 shares. Osterweis Cap Mgmt Incorporated has 17,570 shares for 0.06% of their US portfolio. The Missouri-based Scout Investments Incorporated has invested 0.04% in Adeptus Health Inc (NYSE:ADPT). Creative Planning, a Kansas-based fund reported 230 shares. Jpmorgan Chase Company reported 4,142 shares or 0% of all its holdings. Moreover, Swiss Bank & Trust has 0% invested in Adeptus Health Inc (NYSE:ADPT) for 24,550 shares. Thrivent For Lutherans accumulated 6,590 shares or 0% of the stock. Deerfield Management holds 3.25% or 1.60 million shares in its portfolio.
Adeptus Health Inc. is a patient-centered healthcare company. The company has a market cap of $153.04 million. The Firm is engaged in providing emergency medical care through a network of independent freestanding emergency rooms in the United States and partnerships with various healthcare systems. It has a 1.43 P/E ratio. The Firm has approximately 80 freestanding facilities and over two licensed general hospitals.
ADPT Company Profile
Adeptus Health Inc., incorporated on March 7, 2014, is a patient-centered healthcare company. The Firm is engaged in providing emergency medical care through a network of independent freestanding emergency rooms in the United States and partnerships with various healthcare systems. The Firm has approximately 80 freestanding facilities and over two licensed general hospitals. The Firm owns or operates facilities located in the Houston, Dallas/Fort Worth, San Antonio and Austin, Texas markets; Colorado Springs and Denver, Colorado markets, and Phoenix, Arizona market.
More notable recent Adeptus Health Inc (NYSE:ADPT) news were published by: Prnewswire.com which released: “Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Adeptus Health Inc.” on November 02, 2016, also Businesswire.com with their article: “ADPT STOCK LOSS ALERT: Rosen Law Firm Reminds Adeptus Health Inc. Investors of …” published on November 02, 2016, Globenewswire.com published: “ADEPTUS HEALTH INVESTOR ALERT: Hagens Berman Alerts Adeptus Health Inc …” on November 03, 2016. More interesting news about Adeptus Health Inc (NYSE:ADPT) were released by: Marketwatch.com and their article: “Adeptus Health’s stock plummets as fears of a liquidity crunch prompts downgrade” published on November 02, 2016 as well as Prnewswire.com‘s news article titled: “Harwood Feffer LLP Announces Investigation of Adeptus Health Inc.” with publication date: October 31, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.